Literature DB >> 26638943

Letter: promising results of Helicobacter pylori eradication with vonoprazan-based triple therapy after failure of proton pump inhibitor-based triple therapy.

T Inaba1, M Iwamuro2,3, T Toyokawa4, H Okada5,6.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 26638943     DOI： 10.1111/apt.13462

Source DB:  PubMed          Journal:  Aliment Pharmacol Ther        ISSN： 0269-2813            Impact factor:   8.171


× No keyword cloud information.
  7 in total

Review 1.  Efficacy of Vonoprazan-Based Triple Therapy for Helicobacter pylori Eradication: A Multicenter Study and a Review of the Literature.

Authors:  Hiroki Tanabe; Katsuyoshi Ando; Kiichi Sato; Takahiro Ito; Mitsuru Goto; Tomonobu Sato; Akihiro Fujinaga; Toru Kawamoto; Tatsuya Utsumi; Nobuyuki Yanagawa; Eiichiro Ichiishi; Takaaki Otake; Yutaka Kohgo; Yoshiki Nomura; Nobuhiro Ueno; Hiroko Sugano; Shin Kashima; Kentaro Moriichi; Mikihiro Fujiya; Toshikatsu Okumura
Journal:  Dig Dis Sci       Date:  2017-06-29       Impact factor: 3.199

Review 2.  Eradication of Helicobacter pylori Infection.

Authors:  Elizabeth A Marcus; George Sachs; David R Scott
Journal:  Curr Gastroenterol Rep       Date:  2016-07

Review 3.  Vonoprazan-based therapy for Helicobacter pylori eradication: experience and clinical evidence.

Authors:  Yuko Akazawa; Daisuke Fukuda; Yutaka Fukuda
Journal:  Therap Adv Gastroenterol       Date:  2016-09-22       Impact factor: 4.409

Review 4.  The role of acid inhibition in Helicobacter pylori eradication.

Authors:  David R Scott; George Sachs; Elizabeth A Marcus
Journal:  F1000Res       Date:  2016-07-19

Review 5.  Potent Potassium-competitive Acid Blockers: A New Era for the Treatment of Acid-related Diseases.

Authors:  Tadayuki Oshima; Hiroto Miwa
Journal:  J Neurogastroenterol Motil       Date:  2018-07-30       Impact factor: 4.924

Review 6.  Role of Vonoprazan in Helicobacter pylori Eradication Therapy in Japan.

Authors:  Mitsushige Sugimoto; Yoshio Yamaoka
Journal:  Front Pharmacol       Date:  2019-01-15       Impact factor: 5.810

7.  Comment #2 on "First-Line Helicobacter pylori Eradication with Vonoprazan, Clarithromycin, and Metronidazole in Patients Allergic to Penicillin".

Authors:  Davide Giuseppe Ribaldone; Marco Astegiano
Journal:  Gastroenterol Res Pract       Date:  2018-12-16       Impact factor: 2.260
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.